Avelumab (anti-PD-L1), CAS [[1537032-82-8]]

Produktübersicht

• Artikelname: Avelumab (anti-PD-L1), CAS [[1537032-82-8]]
• Artikelnummer: MCE-HY-108730A
• Hersteller Artikelnummer: HY-108730A
• Alternativnummer: MCE-HY-108730A-10MG,MCE-HY-108730A-5MG,MCE-HY-108730A-1MG
• Hersteller: MedchemExpress
• Kategorie: Antikörper

Produktbeschreibung

Avelumab (anti-PD-L1) a fully human IgG1 anti-PD-L1 monoclonal antibody (mAb) with potential antibody-dependent cell-mediated cytotoxicity (ADCC). Avelumab (anti-PD-L1) enhances ADCC on several cancer cell lines expressing PD-L1. Avelumab (anti-PD-L1) can be used for the study of chordoma[1].

Produkteigenschaften

• Molekulargewicht: (150 kDa)
• Reinheit: 97.44
• CAS Nummer: [1537032-82-8]
• Target-Kategorie: PD-1/PD-L1

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Inhibitory Antibodies